Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC04	PRASOLAN	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	230,373 L.L
A02BC04	PULOROS 28	G	Rabeprazole sodium - 20mg	20mg	Tablet, gastroresistant	706,861 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A02BC04	PARIET	B	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	779,429 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, film coated	212,327 L.L
A02BC04	RAMEP	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	518,809 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 10mg	10mg	Tablet, film coated	212,327 L.L
L04AA04	THYMOGLOBULINE 5mg/ml	BioTech	Rabbit anti-human thymocyte immunoglobulin - 25mg/5ml	25mg/5ml	Injectable powder for solution	21,928,046 L.L
N05AH04	QUETIAPINE BIOGARAN L.P.	G	Quetiapine fumarate - 50mg	50mg	Tablet, prolonged release	1,010,570 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 50mg	50mg	Tablet, extended release	533,505 L.L
N05AH04	QUETIAPINE BIOGARAN L.P.	G	Quetiapine fumarate - 400mg	400mg	Tablet, prolonged release	2,612,430 L.L
N05AH04	QUETIAKEY	G	Quetiapine fumarate - 300mg	300mg	Tablet, film coated	1,947,228 L.L
N05AH04	QUETIAPINE BIOGARAN L.P.	G	Quetiapine fumarate - 300mg	300mg	Tablet, prolonged release	1,759,090 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 300mg	300mg	Tablet, extended release	2,535,831 L.L
N05AH04	SEROPINE XR 300	G	Quetiapine fumarate - 300mg	300mg	Tablet, extended release	4,744,660 L.L
N05AH04	PMS-QUETIAPINE	G	Quetiapine fumarate - 25mg	25mg	Tablet	814,369 L.L
N05AH04	SEROPINE 25	G	Quetiapine fumarate - 25mg	25mg	Tablet, film coated	1,233,647 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 200mg	200mg	Tablet, extended release	2,116,552 L.L
N05AH04	PMS-QUETIAPINE	G	Quetiapine fumarate - 100mg	100mg	Tablet	1,890,786 L.L
N05AH04	SEROPINE 100	G	Quetiapine fumarate - 100mg	100mg	Tablet, film coated	1,996,950 L.L
N05AH04	JOSWE QUZAL 400	G	Quetiapine - 400mg	400mg	Tablet	2,697,092 L.L
N05AH04	JOSWE QUZAL 400	G	Quetiapine - 400mg	400mg	Tablet	5,124,071 L.L
N05AH04	QUETIAPINE/ GENEPHARM	G	Quetiapine - 300mg	300mg	Tablet, film coated	1,988,887 L.L
N05AH04	JOSWE QUZAL 25	G	Quetiapine - 25mg	25mg	Tablet	258,018 L.L
N05AH04	JOSWE QUZAL 25	G	Quetiapine - 25mg	25mg	Tablet	490,503 L.L
N05AH04	QUETIAPINE/ GENEPHARM	G	Quetiapine - 25mg	25mg	Tablet, film coated	712,237 L.L
N05AH04	JOSWE QUZAL 200	G	Quetiapine - 200mg	200mg	Tablet	1,130,172 L.L

...

189